BETA: New Treatment Newsletter Available; First Issue, AZT

The first issue of the Bulletin of Experimental Treatments for AIDS (BETA), published by the San Francisco AIDS
Foundation, is now in press and will be available soon. Copies can be ordered now (see below).
BETA "is published as an educational resource for people considering experimental treatments for AIDS, ARC and HIV infection". It "reviews available scientific data on AIDS treatments as well as anecdotal information provided by
physicians, researchers, people with AIDS and ARC, and individuals infected with HIV". Publication by BETA of
information about a treatment does not, of course, imply endorsement of that treatment by the San Francisco AIDS
Foundation.
The first issue, on AZT, gives a readable, comprehensive overview on the use of the drug--including areas of controversy where physicians disagree. About five thousands words in length, the article includes:
* Dosage, toxicity, and side effects;
* Combining AZT with other drugs;
* AZT use by asymptomatic seropositives--pro and con;
* Experiences of people taking AZT;
* Physicians' comments;
* A glossary; and
* A resource guide to experimental treatment information.
Each issue of BETA gets a careful medical review by the Scientific Review Committee of the San Francisco AIDS
Foundation.
For a copy of BETA issue #1, call the San Francisco AIDS Foundation, (415) 863-AIDS; or in Northern California call
toll-free (800) FOR-AIDS. It's free in San Francisco.

**************************************************